News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Clinical News & Stories
Clinical, Research
mRNA-Based Therapy Offers New Hope Against High-Risk Melanoma
Siteman Cancer Center served as a major, early clinical trial site for groundbreaking vaccine In a major announcement, an experimental mRNA vaccine has been shown in global clinical trials to prevent melanoma from returning or spreading in high-risk melanoma patients when combined with the immunotherapy drug pembrolizumab, known commercially as Keytruda, and given after surgery. The […]
Clinical, In the Media, Staff/Faculty Update
WashU Medicine Appoints New Chief of Head and Neck Surgery
Andrés M. Bur, MD, FACS, a nationally known oncologist and reconstructive surgeon, will also co-lead the Head and Neck Tumor Center at Siteman Cancer Center Andrés M. Bur, MD, FACS, has been named chief of the Division of Head and Neck Surgery in the Department of Otolaryngology — Head & Neck Surgery at WashU Medicine […]
Clinical, Research
Finding Order in the Inner Chaos of our Cells
New technique wrangles evasive proteins to dissect the cause of diseases and design potential new therapeutics The vast majority of proteins in our bodies contain regions that are in a constant state of wiggling, shape-shifting every few nanoseconds to completely change how they look. Information on how these shapeshifting proteins work is critical to understanding […]
Clinical, In the Media, Research
New Approach to Designing Drugs Supercharges Cancer Medication
Shape-shifting drug hits tumors in multiple ways, improves outcomes in mice Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drug, often given to patients for whom standard chemotherapy has not worked. The drugs are precise, but can attack only one kind of target […]
Clinical, In the Media, Research
The Future of Brain Tumor Care is Being Built Now — at Siteman Cancer Center
WashU Medicine experts at Siteman’s Brain Tumor Center are accelerating the science that will create a new standard and new survivorship for brain tumor care For years, progress against glioblastoma has been measured in small steps with only slight improvements in survival. Now, at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, bold research and remarkable advances against this deadliest form of […]
Clinical, In the Media
Siteman Cancer Center Radiation Therapy Recognized for Excellence
Reaccreditation by the American Society for Radiation Oncology underscores Siteman’s enterprise-wide commitment to adult and pediatric patient-centered care The Department of Radiation Oncology at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has again been recognized as one of the best radiation oncology centers in the nation. The recognition comes from its reaccreditation by the American Society […]
Clinical, In the Media, Research
Tumor Markers May Help Doctors Decide Which Head and Neck Cancer Patients Need Immunotherapy Before Surgery
WashU Medicine physician-scientists at Siteman Cancer Center identify a promising way to help guide immunotherapy treatment decisions and enhance patient care Building upon more than a decade of investigator-initiated clinical trials at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, researchers have identified a malignant cell biomarker that may predict which patients will respond to the […]
Clinical, In the Media, Research
Innovative CAR-T cell therapy receives FDA breakthrough therapy designation
Immunotherapy for aggressive T-cell cancers developed by WashU Medicine researchers moves to faster approval pathway A cell-based immunotherapy designed to treat rare and aggressive types of blood cancer has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine in St. Louis, this […]
Clinical, In the Media, Research
FDA Breakthrough Therapy Designation Reflects Practice-Changing Trends Only at Siteman
Recognition follows strong early clinical results for a novel off-the-shelf CAR T therapy targeting rare and aggressive T-cell malignancies A novel off-the-shelf CAR T-cell therapy pioneered at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is gaining national recognition after delivering striking clinical results in patients with rare and aggressive blood cancers. The FDA […]
Clinical, In the Media
Gary C. Werths Building at Siteman Earns LEED Gold
Project team identified more environmentally friendly solutions throughout the building process The Gary C. Werths Building at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has earned Leadership in Energy and Environmental Design (LEED) Gold certification from the U.S. Green Building Council. Buildings that achieve this recognition must meet stringent criteria in categories […]